News | January 31, 2026
Astec LifeSciences posts robust Q3 growth
The company’s total income jumped 31% year-on-year to Rs 125.5 crore
The company’s total income jumped 31% year-on-year to Rs 125.5 crore
Eltrombopag tablets will be produced at the group’s formulation manufacturing facility at SEZ, Ahmedabad
Receiving Orphan Drug Designation is an important milestone in the clinical development of CK0804 for myelofibrosis
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
Clinical trials found that 77% of patients went into remission after receiving obe-cel
The therapy -- Ryoncil (remestemcel-L-rknd) -- will be tested in adults with severe steroid-refractory acute graft-versus-host disease
_256_384.png)
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
Hyaluronic acid is among the world's most valuable biopolymers, with applications spanning from dermal fillers and wound healing to drug delivery and tissue engineering
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
